Introduction 68
Rift Valley fever (RVF) is a mosquito-borne viral disease with potential to generate a public 69 health emergency [1] . In humans, infection leads to a great variety of clinical manifestations 70 that range from a febrile influenza-like illness to hepatitis with fatal hemorrhagic fever, 71 encephalitis and retinitis [2, 3] . In ruminant species, a wide variation in susceptibility to RVF 72 disease is observed among different individuals. Some infected animals suffer from 73 unapparent or moderate febrile reactions while others develop high fevers and severe 74 prostration, which may lead to death in the most susceptible animals [4] [5] [6] . Sequence analysis 75 of RVF virus (RVFV) strains collected during the 1977-1979 Egyptian outbreak has shown 76 that, although all virus isolates carried virtually identical genotypes, remarkable differences 77 were observed in pathogenesis across human and animal populations [7] . These findings 78 suggest that the different pathogenic phenotypes were not linked to specific mutations in the 79 viral genome but could rather be caused by variations in dose and route of virus exposure and 80 by host-related factors including age, sex, overall immune response, nutritional status and 81 genetic variants. 82
Careful control of experimental conditions of infection in rodent models have helped 83 establishing host genetic factors as important determinants in RVF disease severity. The 84 infection of laboratory rodents mimics several features of RVFV-induced pathology in 85 humans, including hepatitis with liver necrosis and meningoencephalitis [8, 9] . The first rat 86 models consisted of the Wistar-Furth (WF) inbred strain which is highly susceptible to the 87 hepatitis induced by subcutaneous inoculation with RVFV, while the Lewis (LEW) strain is 88 largely resistant [8, 10] . Notably, WF rats were not uniformly susceptible to different RVFV 89 strains [11] . Inhalation exposure to RVFV confirmed the extreme susceptibility of the WF 90 strain to RVFV-induced hepatitis [12] . The segregation analysis of the RVFV susceptible 91 5 phenotype in LEW and WF backcrosses suggested a simple Mendelian dominant control [10] . 92 A WF.LEW congenic strain resistant to the fatal hepatitis was created by repeated 93 backcrosses from the resistant LEW to the WF susceptible genetic background [13] . A single 94 region on rat chromosome (Chr) 3 was shown to significantly increase the survival rate of 95 animals carrying the LEW haplotype [14] but the gene accounting for this improved 96
resistance has yet to be identified. 97
Mouse inbred strains also exhibit differences in their susceptibility to an infection with 98 RVFV. In one study, the subcutaneous infection of BALB/c mice with 10 3 plaque-forming 99 units (PFU) of the ZH501 RVFV strain led to an extensive infection of the liver [9]. The 100 resulting liver disease accounted for the death of most animals between days 3 and 6 post 101 infection (p.i.). Mice that survived this early liver disease later developed encephalitis and 102 died around day 8 p.i. [9] . In another study, C57BL/6 mice appeared more susceptible than 103 BALB/c mice under similar experimental conditions and succumbed to acute liver disease 104 within 4 days [15] . We have tested the susceptibility of additional strains derived from 105 various Mus musculus subspecies trapped in the wild. The most severely affected strain 106 within this collection, MBT/Pas (MBT), developed very early onset RVF disease. After 107 intraperitoneal infection with 10 2 PFU of virulent RVFV strain, either Egyptian ZH548 or 108 Kenya 98, MBT mice died more rapidly than BALB/c or C57BL/6 mice [16] . It is worth 109 noting that MBT mice are susceptible to RVFV but resistant to several other viruses [16] , 110 suggesting that the susceptibility to RVFV exhibited by MBT mice is not attributable to 111 generalized immunodeficiency. In flow cytometry studies, we have recently shown that MBT 112 mice displayed several immunological alterations after RVFV infection. Furthermore, these 113 mice failed to prevent high viremia and viral antigen loads in the blood, spleen, and liver [17] . 114
We also showed that, in MBT mice, RVF susceptibility is inherited in a complex polygenic 115 fashion and we identified three genomic intervals on Chr 2, 11 and 5 affecting survival time 116 6 after RVFV infection. Each of these MBT-derived intervals, designated Rift Valley fever 117 susceptibility 1 (Rvfs1), Rvfs2 and Rvfs3 respectively, conferred reduced survival time in 118 C.MBT congenic strains in which these intervals had been transferred onto the less 119 susceptible BALB/c genetic background [18] . The pathogenic mechanisms for the early death 120 induced by RVFV in the C.MBT congenic strains are currently unknown. 121
In this study, we investigated the phenotypic features associated with morbidity in BALB/c 122 mice congenic for the MBT-derived Rvfs2 interval, i.e. C.MBT-Rvfs2 mice. We focused our 123 investigations on male mice which exhibit slightly higher susceptibility to RVFV infection 124 MBT strain on the BALB/c background ( Fig 1A) [18]. The challenge of C.MBT-Rvfs2 mice 141 with 10 2 PFU of the ZH548 RVFV strain showed that Rvfs2 has a strong effect on 142 susceptibility to RVFV. More than 50% of C.MBT-Rvfs2 mice died within 4 days after 143 infection with RVFV, whereas half of BALB/c mice survived for over 8 days (Mantel-Cox's 144 Logrank test, P<0.0001) ( Fig 1B) . and from day 7 to day 9 p.i. Between these two intervals their body weight remained stable. 158
By contrast, C.MBT-Rvfs2 mice lost weight rapidly from day 3 p.i. until their death (Fig 2A) . 159
No differences were found between the two strains in body weight loss at days 3 and 4 (two-160 8 way ANOVA, P(strain effect)=0.54). Temperature measurements indicated that neither 161 BALB/c nor C.MBT-Rvfs2 mice became febrile during the course of infection. A significant 162 drop in body temperature was observed one day before death in both inbred strains, regardless 163 of the cause of death ( Fig 2B) . Overall, no differences in body temperature between BALB/c 164 and congenic mice were found (two-way ANOVA, P(strain effect)=0.69). As RVFV is known 165 to be a hepatotropic virus [19] , blood levels of liver enzymes were measured during the 166 disease course in uninfected and infected BALB/c and C.MBT-Rvfs2 mice. Alanine 167 aminotransferase (ALT) and aspartate transaminase (AST) peaked on day 4 p.i. in both 168 infected strains ( Fig 2C and 2D) , indicating hepatocyte damage. After day 5 p.i., AST and 169 ALT serum levels decreased slowly in infected BALB/c mice and returned to normal levels 170 on day 8 p.i., suggesting recovery from the liver disease. Altogether the development of the 171 RVF disease in the first 4 days was similar in both inbred strains. 172
BALB/c and C.MBT-Rvfs2 mice exhibit liver damage at days 3 and 4 p.i. 173
We studied in further detail the tissue damage caused by RVFV in the liver of infected 174 BALB/c (N=10) and C.MBT-Rvfs2 (N=8) mice euthanized on day 3 p.i. Histopathological 175 analyses of the liver revealed three different lesion profiles of increasing severity in both 176 mouse genotypes (Fig 3) . Five out of 10 BALB/c and 5/8 C.MBT-Rvfs2 mice exhibited mild, 177 multifocal and well demarcated lesions defined as Profile 1. Liver lesions in these mice were 178 characterized by hepatocyte cell death associated with small inflammatory infiltrates 179 containing fragmented neutrophils ( Fig 3A and 3B ). Immunohistochemical (IHC) labeling 180 directed against the viral N protein was used to identify infected cells (note that the technique 181 used could not provide quantitative information on the infection level in infected cells). This 182 analysis revealed small multifocal foci (less than 100 µm in diameter) of infected hepatocytes 183 ( Fig 3C) . Profile 2 was observed in 3/10 BALB/c and 2/8 C.MBT-Rvfs2 mice. This profile 184 was also characterized by multifocal lesions with hepatocyte cell death. However, lesions 185 9 were more severe, extensive and diffuse ( Fig 3D and 3E) . IHC analyses detected a stronger 186 signal with slightly larger foci of infected hepatocytes ( Fig 3F) The gradual decrease of liver transaminases between days 5 and 8 post-infection in BALB/c 209 mice suggested hepatic tissue regeneration. We further evaluated the extent of liver recovery, 210 by examining histopathological changes in livers of moribund BALB/c mice (N=4) 211 euthanized between day 6 and 9 p.i. (Figs 4 and 5). On day 6 p.i., only minimal lesions were 212 observed ( Fig 4A and 4B) and few RVFV N-positive hepatocytes were detected ( Fig 4C) . An 213 increased number of mitosis as well as a strong and diffuse expression of Ki67 confirmed the 214 proliferation of hepatocytes ( Fig 4D) . By day 8, minimal to mild, subacute to chronic 215 inflammatory lesions were scattered in the liver parenchyma or centered on portal tracts and 216 consisted of small infiltrates of lymphocytes, plasma cells and macrophages (Fig 5A and 5B) . 217
Very few hepatocytes were labeled positively for the RVFV N protein, confirming an 218 efficient viral clearance in the hepatic tissue ( Fig 5C) . Since BALB/c mice exhibited clinical 219 neurological signs, we investigated their brain for infection-related lesions. Histopathological 220 lesions were visible in the brain of moribund BALB/c mice. The virus targeted different brain 221 anatomic structures in each individual mouse, and no pathognomonic lesion profile could be 222 defined ( Fig 5D-I) . We detected (i) subacute leptomeningitis with multifocal infiltration of the 223 leptomeninges by lymphocytes, plasma cells, and neutrophils ( Fig 5D) , and (ii) cell death foci 224 in different locations of the cerebral grey matter, e.g. the outer granular layer or different 225 brain nuclei (Fig 5E, 5F, and 5G ). In these foci, shrinkage of neurons, gliosis, infiltration of 226 neutrophils and strong RVFV N protein immunolabeling of neurons were observed ( Fig 5H  227 and 5I). These lesions were likely the cause of the neurological symptoms and eventual death 228 in BALB/c mice. 229
Elevated viral burden in the blood and liver of C.MBT-Rvfs2 mice 230
In order to assess differences in the viral production, we first measured the titer of infectious 231 viral particles in the blood and liver of BALB/c and C.MBT-Rvfs2 mice on day 3 p.i. by 232 standard plaque assay. The viral titers were about 80-and 100-fold higher in the 233 C.MBT-Rvfs2 blood and liver, respectively, compared with those found in BALB/c mice 234 (Mann Whitney-U test, P<0.001 and P=0.016, respectively; Fig 6A and 6B) . Finally, semi-235 11 quantitative protein analysis of liver extracts at day 3 p.i. by Western blot indicated that high 236 levels of N nucleocapsid and NSs nonstructural viral proteins were found in the liver of 237 C.MBT-Rvfs2, while both viral proteins were undetectable in BALB/c liver ( Fig 6C) despite 238 the same proportions of RVFV-infected cells in the two strains revealed by IHC (Fig 3) . 239
Altogether, these results indicated that, compared to BALB/c mice, C.MBT-Rvfs2 mice have 240 reduced ability to limit the replication of RVFV thus allowing the production of the virus 241 systemically and specifically in the liver at much higher levels. 242
Increased viral replication in C.MBT-Rvfs2-derived cultured primary hepatocytes 243
To further analyze the increased susceptibility of C.MBT-Rvfs2 mice to RVFV-induced liver 244 disease, we derived primary cultured hepatocytes from the liver of BALB/c and C.MBT-Rvfs2 245 uninfected mice. We measured the kinetics of viral production in the culture medium over 60 246 h after infecting hepatocytes with RVFV. While the viral titer remained constant at 300-400 247 PFU/ml in the BALB/c culture, it peaked in C.MBT-Rvfs2-derived hepatocytes at almost 900 248 PFU/ml 24h after infection before decreasing at 48 and 60 hours post-infection (Fig 7) . This 249 increased viral replication in C.MBT-Rvfs2 hepatocytes is likely one of the mechanisms 250 responsible for the enhanced susceptibility to the liver disease conferred by the Rvfs2 locus. 251
Both hematopoietic and non-hematopoietic cells are required for Rvfs2-dependent 252 survival to liver disease 253
We have recently shown that the inbred strain MBT displays multiple immune-related defects 254 in response to RVFV infection [17] . Together with transcriptomics data from a previous study 255
[16], these results suggest that innate immune cells might be the critical determinant for 256 survival to liver disease. To test this hypothesis, we produced chimeric mice using crosswise 257 transplantations of bone-marrow cells after total body irradiation to evaluate whether the 258 effects of Rvfs2 in hematopoietic cells, in non-hematopoietic cells, or in both were required 259 for survival to the RVFV-induced liver disease. We generated BALB/c mice reconstituted 260 We chose to focus our efforts first on Rvfs2, a 17Mb genomic interval, because of its 295 strongest effect. 296 In our mouse model, the animals are infected by intraperitoneal injection of 10 2 PFU of the 297 ZH548 RVFV strain [2, 21] . This virus dose was initially chosen to induce high mortality in 298 both MBT and BALB/c parental strains (S1 Table) . In these conditions, most MBT mice died 299 within 5 days p.i. with the clinical signs of liver disease. By contrast, most BALB/c mice 300 lived beyond that date and exhibited signs of encephalitis, such as paralysis, ataxia, or head-301 14 tilting behavior [16] . Notably, the difference in the days of death between BALB/c and MBT 302 mice was identical at infectious doses ranging from 10 to 1000 PFU (S1 Table) . 303
The pathogenesis induced by the subcutaneous challenge of BALB/c mice with 10 3 PFU 304 ZH501 RVFV has been recently characterized in detail [9, 22] . Approximately 80% of 305 BALB/c mice infected in these conditions were reported to have succumbed with severe liver 306 disease between days 3 and 6 p.i., a much higher percentage than the one observed in our 307 study (<10%). Several experimental factors differ between the two studies. Although ZH501 308 and ZH548 RVFV strains have been isolated in the same hospital during the 1977 Egyptian 309 outbreak, they have distinct passaging history [9] and exhibit a small percentage of nucleotide 310 differences [7, 21, 23]. Therefore, we cannot exclude that ZH501 and ZH548 RVFV strains 311 induce distinct survival rates at day 6 p.i. Based on our previous experiments (S1 Table) , a 312 lower inoculation dose (10 2 instead of 10 3 PFU) is unlikely to be solely responsible for a 313 reduced death rate between days 3 and 6 p.i. in our study. Finally, this difference could be due 314 to mouse sex and genetic background since we used males of the BALB/cByJ inbred strain 315 while the other study was performed on female BALB/c mice, without indication of the 316 substrain. Significant differences between BALB/c substrains have been previously reported 317 with other infectious diseases and immune responses [24, 25] , emphasizing the importance of 318 accurately specifying the animal strain used is such studies. Whatever the reason for this 319 difference in survival rates, our findings are consistent with the biphasic RVF disease 320 reported by Smith and colleagues [9] that consists of an acute liver disease followed by a 321
panencephalitis. 322
Under our conditions, C.MBT-Rvfs2 mice were highly susceptible to, and died from, the 323 early-onset liver disease, while BALB/c mice overcame it and died later of encephalitis. Our 324 results suggest that one of the mechanisms underlying the increased susceptibility of 325 C.MBT-Rvfs2 mice is a higher viral replication rate at the cellular level, as shown in primary 326 15 cultured hepatocytes and by the increased viral load in the liver, despite similar percentage of 327 infected liver cells as assessed by non-quantitative IHC. Altogether, these findings establish 328 the feasibility and exemplify the value of segregating important sub-phenotypes by 329 transferring a single locus, Rvfs2, from the early susceptible to a late susceptible background. 330
Susceptibility to liver disease has also been reported in WF inbred rats after subcutaneous 331 infection with RVFV ZH501 [8] . WF rats died by day 2 post inoculation of liver necrosis, 332
whereas LEW rats were resistant to the liver disease but fairly susceptible to the encephalitis 333 [8, 13] . This susceptibility to liver necrosis occurred in a similar time frame after respiratory 334 infection in WF rats [12] . The pathogenic mechanisms that trigger the susceptibility of WF 335 rats and C.MBT-Rvfs2 mice to RVF hepatic disease may be similar. Indeed, it has been 336 reported that susceptible WF rats had much higher blood viral titers than resistant LEW rats at 337 day 2 p.i. [13] , in line with the higher viral production in hepatocytes from WF rats compared 338 with LEW rats [26] . These data suggest that the rat susceptibility locus also controls the 339 production of RVFV. Recently, a major gene for the susceptibility has been mapped within a 340 region on rat Chr 3 [14] . This rat region has homology with mouse Chr 2, indicating that the 341 rat susceptibility locus and Rvfs2 which maps on mouse Chr 11 do not point at the same 342 gene(s). Therefore, the genetic variations captured in WF rats and MBT mice are different, 343 which makes both rodent models equally interesting and important. 344
In principle, the RVFV-infected host can protect itself from lethal liver disease using two 345 non-mutually exclusive strategies: (i) resistance to reduce viral burden, (ii) tolerance to reduce 346 the negative impact of the viral burden on host fitness [27, 28] . Our study indicates that the 347 main contributor to early lethality of C.MBT-Rvfs2 mice can be attributed to higher levels of 348 RVFV in the blood and liver and higher viral replication rate in hepatocytes compared to 349 BALB/c mice. Whether higher susceptibility to liver disease is only due to lower resistance or 350 also to reduced tolerance remains to be determined. 
Virus production and mouse infection 379
The RVFV strain ZH548, isolated from a male patient with the acute febrile illness at Zagazig 380 fever hospital, Egypt [21, 31] (obtained from Centre National de Référence des Fièvres 381 Hémorragiques Virales, Institut Pasteur, Lyon, France), was used for all infection studies. All 382 experiments that involved virulent RVFV were performed in the biosafety level 3 (BSL3) 383 facilities of the Institut Pasteur, and carried out in compliance with the recommendations of 384 the Institut Pasteur Biosafety Committee (N° 14.320). Stocks of RVFV ZH548 were titrated 385 by plaque assay on monolayers of Vero E6 cells [32] . Infections were carried out on 9 to 13 386 weeks old male mice, in BSL-3 isolators. Mice were infected intraperitoneally with 10 2 PFU 387 of RVFV strain ZH548. Clinical disease scores and mortality were monitored daily for 14 388 18 days following infection. Moribund animals were euthanized. Animals that survived were 389 euthanized on the last day of the monitoring period. 390
Clinical evaluation 391
Implantable Programmable Temperature Transponders (IPTT-300) (Bio Medic Data Systems, 392
Inc., Seaford, DEL, USA) were injected subcutaneously into mice one week prior to 393 challenge with RVFV ZH548, and body temperature was monitored daily. Body weight of 394 ZH548-infected mice was measured daily throughout the course of the experiment to evaluate 395 the daily weight loss. Alanine aminotransferase (ALT) and aspartate aminotransferase (ALT) 396 levels were measured using IDEXX diagnostic panels analyzed on a VetTest chemistry 397 analyzer (IDEXX laboratories, Westbrook, ME, USA) on ZH548-infected mice and 398 uninfected controls. 399
Viral titer, viral RNA load, and expression of N and NSs viral proteins 400
Groups of infected BALB/c and C.MBT-Rvfs2 mice were euthanized on day 3 p.i. Blood was 401 collected by cardiac puncture. The left lateral lobe of the liver was harvested after perfusion 402 from the portal to the cava vein with saline to remove blood-associated RVFV from the 403 tissues. Infectious titers were measured in sera samples and liver homogenates by plaque 404 assay on monolayers of Vero E6 cells [32] . 405
The expression of N and NSs viral proteins was studied by Western blot analysis. Total 406 proteins were extracted from liver samples of two mice used above for viral titration (noted 407 b1, b2, r1 and r2 on figure 6). Protein quantification was done using Micro BCA Protein 408 Assay kit (ThermoFisher Scientific, Waltham, MA). Ten μg of total protein from a cell lysate 409 from AML12 hepatocytes infected with RVFV at an MOI of 3 were used as a positive 410 control. Forty micrograms of total proteins extracted from liver samples and resuspended in 411
Laemmli buffer were run on 14% SDS-polyacrylamide gel and transferred onto nitrocellulose 412 membranes (Amersham, Velizy-Villacoulay, France). Membranes were blocked with a 413
